BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totaling 8,700 shares, an increase of 690.9% from the April 15th total of 1,100 shares. Based on an average daily volume of 7,445 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.0% of the shares of the company are short sold.
BioNxt Solutions Stock Up 9.9%
Shares of OTCMKTS BNXTF opened at $0.35 on Thursday. BioNxt Solutions has a fifty-two week low of $0.26 and a fifty-two week high of $0.80. The firm’s 50-day simple moving average is $0.38 and its 200 day simple moving average is $0.44. The stock has a market cap of $42.88 million, a P/E ratio of -8.75 and a beta of 0.69.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported ($0.01) earnings per share for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Featured Articles
- Five stocks we like better than BioNxt Solutions
- Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar
- Oklo Stock Could Be Ready for Another Massive Run
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
